These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32133619)

  • 1. Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing.
    Acharya P; Mathur M
    Br J Dermatol; 2020 Jul; 183(1):193. PubMed ID: 32133619
    [No Abstract]   [Full Text] [Related]  

  • 2. Vulvar Hailey-Hailey disease treated with low-dose naltrexone: case report and literature review.
    Sousa Gomes M; Araújo Pereira J; Trocado V; Prata JP; Teixeira V; Pinheiro P
    Arch Gynecol Obstet; 2020 Nov; 302(5):1081-1086. PubMed ID: 32776297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Hailey-Hailey disease with low-dose naltrexone.
    Jasans-Barceló M; Curman P; Hagströmer L; Wikstrom JD; Sairafi D
    Br J Dermatol; 2020 Jun; 182(6):1500-1502. PubMed ID: 31912486
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone Therapy for Hailey-Hailey Disease: Confirming My Addiction to Evidence-Based Medicine.
    Heymann WR
    Skinmed; 2019; 17(1):44-45. PubMed ID: 30888948
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): A case series.
    Riquelme-Mc Loughlin C; Riera-Monroig J; Morgado-Carrasco D; Giavedoni P; Podlipnik S; Iranzo P; Mascaró JM
    J Am Acad Dermatol; 2019 Aug; 81(2):644-646. PubMed ID: 31002846
    [No Abstract]   [Full Text] [Related]  

  • 6. Variable Response to Naltrexone in Patients With Hailey-Hailey Disease.
    Cao S; Lilly E; Chen ST
    JAMA Dermatol; 2018 Mar; 154(3):362-363. PubMed ID: 29344611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).
    Ibrahim O; Hogan SR; Vij A; Fernandez AP
    JAMA Dermatol; 2017 Oct; 153(10):1015-1017. PubMed ID: 28768314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone.
    Albers LN; Arbiser JL; Feldman RJ
    JAMA Dermatol; 2017 Oct; 153(10):1018-1020. PubMed ID: 28768313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease.
    Campbell V; McGrath C; Corry A
    Br J Dermatol; 2018 May; 178(5):1196-1198. PubMed ID: 28991360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases.
    Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2019; 23(4):453-454. PubMed ID: 31337235
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report.
    Garayar Cantero M; Canseco Martín M; Aguado García Á; Ruiz-Sánchez D; Valtueña J; Manchado López P
    Dermatol Ther; 2019 May; 32(3):e12892. PubMed ID: 30958613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermpath & Clinic: Hailey Hailey disease treated with low-dose naltrexone.
    Andrea C; Breton AL; Kanitakis J
    Eur J Dermatol; 2021 Oct; 31(5):675-676. PubMed ID: 34903509
    [No Abstract]   [Full Text] [Related]  

  • 13. The uses of naltrexone in dermatologic conditions.
    Lee B; Elston DM
    J Am Acad Dermatol; 2019 Jun; 80(6):1746-1752. PubMed ID: 30582992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalcitrant cases of Hailey-Hailey disease successfully managed with low-dose naltrexone.
    Vyas HR; Shah SR; Patel HS; Shah BJ
    Int J Dermatol; 2023 Mar; 62(3):e149-e151. PubMed ID: 35780232
    [No Abstract]   [Full Text] [Related]  

  • 15. Hailey-Hailey disease: the role of azathioprine an immunomodulator.
    Malan M; Xuejingzi W; Si J; Quan SJ
    Pan Afr Med J; 2019; 32():65. PubMed ID: 31223357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone.
    Kollman N; Bass J
    JAAD Case Rep; 2018 Aug; 4(7):725-727. PubMed ID: 30167446
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign familial pemphigus (Hailey-Hailey disease) responsive to low dose cyclosporine.
    Nanda A; Khawaja F; Harbi R; Nanda M; Dvorak R; Alsaleh QA
    Indian J Dermatol Venereol Leprol; 2010; 76(4):422-4. PubMed ID: 20657133
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of botulinum toxin type A in the treatment of Hailey-Hailey disease.
    Bagherani N; Smoller BR
    Dermatol Ther; 2016 Nov; 29(6):394-395. PubMed ID: 26970226
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral glycopyrrolate for the treatment of Hailey-Hailey disease.
    Kaniszewska M; Rovner R; Arshanapalli A; Tung R
    JAMA Dermatol; 2015 Mar; 151(3):328-9. PubMed ID: 25651401
    [No Abstract]   [Full Text] [Related]  

  • 20. Hailey-Hailey disease (benign familial pemphigus) responsive to treatment with ocrelizumab for multiple sclerosis.
    Adamson SR; Higgins CL; Veysey E
    Br J Dermatol; 2023 Jul; 189(2):232-234. PubMed ID: 37002729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.